These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6444955)

  • 1. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P; Chapuy MC; Vignon E; Briançon D; Charhon S; Meunier PJ
    Nouv Presse Med; 1982 Apr; 11(19):1471-4. PubMed ID: 6210878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dichloromethylene diphosphonate action in hematologic and other malignancies.
    Canfield RE; Siris ES; Jacobs TP
    Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.
    Siris ES; Sherman WH; Baquiran DC; Schlatterer JP; Osserman EF; Canfield RE
    N Engl J Med; 1980 Feb; 302(6):310-5. PubMed ID: 6444241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP; Siris ES; Bilezikian JP; Baquiran DC; Shane E; Canfield RE
    Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES; Hyman GA; Canfield RE
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
    Attardo-Parrinello G; Merlini G; Pavesi F; Crema F; Fiorentini ML; Ascari E
    Arch Intern Med; 1987 Sep; 147(9):1629-33. PubMed ID: 2957971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
    Conte N; Di Virgilio R; Roiter I; Caberlotto L
    Tumori; 1985 Feb; 71(1):51-4. PubMed ID: 3157251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Laine H
    Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.
    Jung A
    Am J Med; 1982 Feb; 72(2):221-6. PubMed ID: 6460442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bone metastases with dichloromethylene bisphosphonate.
    Francini G; Gonnelli S; Petrioli R; Conti F; Paffetti P; Gennari C
    J Clin Oncol; 1992 Apr; 10(4):591-8. PubMed ID: 1532198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hypercalcemia of tumoral origin with two diphosphonates].
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1822-4. PubMed ID: 6792698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
    Biomed Pharmacother; 1988; 42(2):111-6. PubMed ID: 2971403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral diphosphonates for treating malignant hypercalcemia.
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC; Charhon SA; Meunier PJ
    Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
    Paterson AD; Kanis JA; Cameron EC; Douglas DL; Beard DJ; Preston FE; Russell RG
    Br J Haematol; 1983 May; 54(1):121-32. PubMed ID: 6221750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.